Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- FDA's Prasugrel Machinations Seem Bound to Attract Doubt
- UPDATE: Dr. Sanjay Kaul was bounced from the FDA's prasugrel panel after Eli Lilly called the FDA to question his inclusion on the panel, according to HeartWire. The FDA has admitted it made a "mistake" by axing Kaul. "At every step of the way there were errors by multiple parties,"...
- Blog posts 2009-02-23
Additional Resources
- More Bad News for Lilly's Prasugrel
- The bleeding risks of Eli Lilly's new blood thinner, prasugrel, are less clear than the company thinks, according to a Cedars Sinai cardiologist. The drug -- which Lilly hopes will be huge -- is currently under review by the FDA but has suffered a series of delays that have set...
- Blog posts 2008-11-11
- << Previous
- page 1 of 1
- Next >>
